Hepatitis C News and Research

Latest Hepatitis C News and Research

Public health school deans condemn CIA's use of fake vaccination campaign in letter to Obama

"The deans of the nation's top public health schools sent a letter to President Obama on Monday condemning the Central Intelligence Agency's use of a vaccination campaign ruse in the hunt for Osama bin Laden," the New York Times reports.

9 Jan 2013

Adolescents may lose hepatitis B virus protection despite vaccination as infants

New research reveals that a significant number of adolescents lose their protection from hepatitis B virus (HBV) infection, despite having received a complete vaccination series as infants. Results in the January 2013 issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, suggest teens with high-risk mothers (those positive for HBeAg) and teens whose immune system fails to remember a previous viral exposure (immunological memory) are behind HBV reinfection.

8 Jan 2013

Newly discovered gene predicts HCV interferon response

Researchers have discovered a gene which interferes with the clearance of hepatitis C virus infection.

7 Jan 2013

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.

7 Jan 2013

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

"Thanks to a herculean effort by health advocates, 78 percent of children in low-income countries receive the basic set of childhood vaccines, covering diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenza," a Bloomberg View editorial states.

3 Jan 2013

Few hepatitis C patients receive complete treatment

Less than 10% of patients with hepatitis C receive the treatment they need to achieve a sustained virologic response, results from a systematic review show.

31 Dec 2012

Hepatitis C virus takes over invaded cell by hijacking protein making machinery

Researchers at the University of Colorado School of Medicine have figured out intimate details of how the hepatitis C virus takes over an invaded cell, a breakthrough that could point to way for new treatments for the virus.

29 Dec 2012

SVR associated with prolonged overall survival in patients with chronic HCV infection

Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the December 26 issue of JAMA.

26 Dec 2012

NanoViricides to advance influenza drug candidate with completed $5M funding

NanoViricides, Inc., announced today that it has received the final tranche of $2.5M from Seaside 88, LP, thereby completing the total of a $5M financing. This raise, and the receipt of the initial $2.5M tranche, was previously announced on June 29, 2012.

25 Dec 2012

Blogs respond to attacks against polio workers in Pakistan

The following blog posts were published in response to a series of attacks against polio workers in Pakistan this week, which have left eight dead since Monday.

21 Dec 2012

Top-line results from Medivir's simeprevir phase III trials on genotype 1 HCV infection

Medivir AB today announced top-line results from three pivotal phase III trials examining the one pill, once-daily, investigational protease inhibitor, simeprevir (TMC435), administered with pegylated interferon and ribavirin.

20 Dec 2012

Zoo data show low incidence of animal–human infection

Zoonotic transmission rates are low and the risk for animal–human infection is well managed, show zoo data spanning 19 years.

19 Dec 2012

Study highlights need for health services and social support for parolees

More than 40% of parolees and releases sent to the Bronx from New York State prisons have two or more major chronic conditions, a study to be released today at a public briefing at Health People: Community Preventive Health Institute in the Bronx shows.

19 Dec 2012

MiR-122 plays a critical role in the life cycle of hepatitis C virus

Hepatitis C virus has evolved to invade and hijack the basic machinery of the human liver cell to ensure its survival and spread. Researchers at the University of North have discovered how hepatitis C binds with and repurposes a basic component of cellular metabolism known as a microRNA to help protect and replicate the virus.

19 Dec 2012

Long-term antiviral HBV treatment advocated

Study results support the long-term use of tenofovir disoproxil fumarate for chronic hepatitis B virus, showing that it can suppress the virus and lead to regression of fibrosis and cirrhosis in patients after 5 years’ treatment.

17 Dec 2012

New report provides snapshot of Canada's cancer system

A comprehensive report released today by the Canadian Partnership Against Cancer provides a snapshot of how Canada's cancer system is performing in key areas from prevention through to patient experience and outcomes.

17 Dec 2012

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Malaria is an infection caused by a parasite called plasmodium, which is transmitted from person to person by females of some species of mosquito. It is primarily a disease of tropical countries.

14 Dec 2012

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Medivir AB, announced today the initiation of cohort 2 in the interferon-free phase II trial combining simeprevir with sofosbuvir (GS7977) based on a safety and efficacy planned interim analysis of cohort 1 including prior null responder HCV genotype 1 infected patients without advanced hepatic fibrosis.

13 Dec 2012

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients with multiple sclerosis (MS).

13 Dec 2012

Researchers discover a trigger by which the HCV enters liver cells

Researchers at the University of Southern California (USC) have discovered a trigger by which the Hepatitis C virus enters liver cells ─ shedding light on how this serious and potentially deadly virus can begin to damage the liver.

13 Dec 2012

Hepatitis C News and Research

Latest Hepatitis C News and Research

Public health school deans condemn CIA's use of fake vaccination campaign in letter to Obama

Adolescents may lose hepatitis B virus protection despite vaccination as infants

Newly discovered gene predicts HCV interferon response

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

Few hepatitis C patients receive complete treatment

Hepatitis C virus takes over invaded cell by hijacking protein making machinery

SVR associated with prolonged overall survival in patients with chronic HCV infection

NanoViricides to advance influenza drug candidate with completed $5M funding

Blogs respond to attacks against polio workers in Pakistan

Top-line results from Medivir's simeprevir phase III trials on genotype 1 HCV infection

Zoo data show low incidence of animal–human infection

Study highlights need for health services and social support for parolees

MiR-122 plays a critical role in the life cycle of hepatitis C virus

Long-term antiviral HBV treatment advocated

New report provides snapshot of Canada's cancer system

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Researchers discover a trigger by which the HCV enters liver cells

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Hepatitis C News and Research

Latest Hepatitis C News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in